Premier Fund Managers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-250,099
| Closed | -$38.9M | – | 175 |
|
|
2025
Q1 | $38.9M | Buy |
250,099
+99
| +0% | +$15.4K | 1.45% | 32 |
|
|
2024
Q4 | $45.8M | Hold |
250,000
| – | – | 1.63% | 31 |
|
|
2024
Q3 | $49.6M | Buy |
250,000
+90,000
| +56% | +$17.8M | 1.76% | 28 |
|
|
2024
Q2 | $33.2M | Hold |
160,000
| – | – | 1.33% | 35 |
|
|
2024
Q1 | $43.1M | Sell |
160,000
-44,000
| -22% | -$11.9M | 1.71% | 30 |
|
|
2023
Q4 | $48.7M | Sell |
204,000
-16,000
| -7% | -$3.82M | 2.1% | 20 |
|
|
2023
Q3 | $43M | Hold |
220,000
| – | – | 2.02% | 24 |
|
|
2023
Q2 | $46M | Hold |
220,000
| – | – | 1.83% | 23 |
|
|
2023
Q1 | $43.6M | Hold |
220,000
| – | – | 1.72% | 29 |
|
|
2022
Q4 | $49.2M | Buy |
220,000
+109,000
| +98% | +$24.4M | 1.92% | 17 |
|
|
2022
Q3 | $21.1M | Buy |
111,000
+70,000
| +171% | +$13.3M | 1.58% | 27 |
|
|
2022
Q2 | $8.99M | Hold |
41,000
| – | – | 0.4% | 69 |
|
|
2022
Q1 | $11.9M | Sell |
41,000
-39,300
| -49% | -$11.4M | 0.42% | 71 |
|
|
2021
Q4 | $30.2M | Sell |
80,300
-16,200
| -17% | -$6.09M | 0.97% | 43 |
|
|
2021
Q3 | $40.9M | Sell |
96,500
-900
| -0.9% | -$381K | 1.32% | 28 |
|
|
2021
Q2 | $36.2M | Buy |
97,400
+5,800
| +6% | +$2.16M | 1.23% | 37 |
|
|
2021
Q1 | $26.4M | Hold |
91,600
| – | – | 1.02% | 38 |
|
|
2020
Q4 | $22.8M | Hold |
91,600
| – | – | 0.98% | 38 |
|
|
2020
Q3 | $20.4M | Hold |
91,600
| – | – | 1.17% | 32 |
|
|
2020
Q2 | $16M | Buy |
+91,600
| New | +$16M | 0.99% | 40 |
|